Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Link between hypertension and vitamin D deficiency

Study locks in link between hypertension and vitamin D deficiency

A new genetic study led by University of South Australia epidemiologist Professor Elina Hyppönen has confirmed a causal link between high blood pressure (hypertension) and deficiencies in vitamin D.

The findings just published in the Lancet Diabetes and Endocrinology journal, drew on a sample of more than 146,000 records to assess the association.

“We set up a Mendelian randomisation study using genetic data from the D-CarDia collaboration involving more than 140,000 individuals of European ancestry from across Europe and North America,” Prof Hyppönen says.

“We used two common genetic variants that affect circulating 25-hydroxyvitamin D concentrations, which are generally used to determine a person’s vitamin D status, to measure the causal effect between vitamin D status and blood pressure and hypertension risk.

“And what we found was that for each 10 per cent increase in 25-hydroxyvitamin D concentration there were drops in both diastolic and systolic blood pressure.

“Statistically the association translated to just over an eight percent decrease in the odds of developing hypertension.”

Prof Hyppönen says that while there have been some small scale studies and randomised trials, until now, a direct causal link between vitamin D and a lowering of blood pressure has not been shown.

“These findings may have important implications to individuals who are vitamin D deficient,” Prof Hyppönen believes. “The potential to prevent and reduce high blood pressure with vitamin D in place of more expensive medications is certainly something researchers can now usefully explore in greater depth.”

According to Prof Hyppönen while Mendelian randomisation helps to determine cause and effect by using genetic data and avoiding bias, there is always a possibility that the findings could occur by chance.

“What will be really important is an independent replication of this study,” Prof Hyppönen says.

“And to advance the work further, we need to do more research using randomised controlled studies to look at and confirm causality and importantly assess the clinical benefits of vitamin D supplements and dosage levels.”

This significant research into the relationship between vitamin D and hypertension was funded by the British Heart Foundation, UK Medical Research Council, and Academy of Finland.

Prof Hyppönen is a member of UniSA’s School of Population Health working at the South Australian Health and Medical Research Institute.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news